Your browser doesn't support javascript.
loading
The usability of daytime and night-time heart rate dynamics as digital biomarkers of depression severity.
Siddi, S; Bailon, R; Giné-Vázquez, I; Matcham, F; Lamers, F; Kontaxis, S; Laporta, E; Garcia, E; Lombardini, F; Annas, P; Hotopf, M; Penninx, B W J H; Ivan, A; White, K M; Difrancesco, S; Locatelli, P; Aguiló, J; Peñarrubia-Maria, M T; Narayan, V A; Folarin, A; Leightley, D; Cummins, N; Vairavan, S; Ranjan, Y; Rintala, A; de Girolamo, G; Simblett, S K; Wykes, T; Myin-Germeys, I; Dobson, R; Haro, J M.
Affiliation
  • Siddi S; Parc Sanitari Sant Joan de Déu, Fundació Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Barcelona, Spain.
  • Bailon R; Aragón Institute of Engineering Research (I3A), University of Zaragoza, Zaragoza, Spain.
  • Giné-Vázquez I; Centros de investigación biomédica en red en el área de bioingeniería, biomateriales y nanomedicina (CIBER-BBN), Madrid, Spain.
  • Matcham F; Parc Sanitari Sant Joan de Déu, Fundació Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Barcelona, Spain.
  • Lamers F; King's College London, Institute of Psychiatry, Psychology and Neuroscience, London, UK.
  • Kontaxis S; School of Psychology, University of Sussex, Falmer, UK.
  • Laporta E; Department of Psychiatry, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands.
  • Garcia E; Amsterdam Public Health Research Institute, Amsterdam, the Netherlands.
  • Lombardini F; Aragón Institute of Engineering Research (I3A), University of Zaragoza, Zaragoza, Spain.
  • Annas P; Centros de investigación biomédica en red en el área de bioingeniería, biomateriales y nanomedicina (CIBER-BBN), Madrid, Spain.
  • Hotopf M; Centros de investigación biomédica en red en el área de bioingeniería, biomateriales y nanomedicina (CIBER-BBN), Madrid, Spain.
  • Penninx BWJH; Centros de investigación biomédica en red en el área de bioingeniería, biomateriales y nanomedicina (CIBER-BBN), Madrid, Spain.
  • Ivan A; Microelectrónica y Sistemas Electrónicos, Universidad Autónoma de Barcelona, CIBERBBN, Barcelona, Spain.
  • White KM; Parc Sanitari Sant Joan de Déu, Fundació Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Barcelona, Spain.
  • Difrancesco S; H. Lundbeck A/S, Valby, Denmark.
  • Locatelli P; King's College London, Institute of Psychiatry, Psychology and Neuroscience, London, UK.
  • Aguiló J; South London and Maudsley NHS Foundation Trust, London, UK.
  • Peñarrubia-Maria MT; Department of Psychiatry, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands.
  • Narayan VA; Amsterdam Public Health Research Institute, Amsterdam, the Netherlands.
  • Folarin A; King's College London, Institute of Psychiatry, Psychology and Neuroscience, London, UK.
  • Leightley D; King's College London, Institute of Psychiatry, Psychology and Neuroscience, London, UK.
  • Cummins N; Department of Psychiatry, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands.
  • Vairavan S; Department of Engineering and Applied Science, University of Bergamo, Bergamo, Italy.
  • Ranjan Y; Centros de investigación biomédica en red en el área de bioingeniería, biomateriales y nanomedicina (CIBER-BBN), Madrid, Spain.
  • Rintala A; Microelectrónica y Sistemas Electrónicos, Universidad Autónoma de Barcelona, CIBERBBN, Barcelona, Spain.
  • de Girolamo G; Catalan Institute of Health, Primary Care Research Institute (IDIAP Jordi Gol), CIBERESP, Barcelona, Spain.
  • Simblett SK; Research and Development Information Technology, Janssen Research & Development, LLC, Titusville, NJ, USA.
  • Wykes T; King's College London, Institute of Psychiatry, Psychology and Neuroscience, London, UK.
  • Myin-Germeys I; King's College London, Institute of Psychiatry, Psychology and Neuroscience, London, UK.
  • Dobson R; Research and Development Information Technology, Janssen Research & Development, LLC, Titusville, NJ, USA.
  • Haro JM; King's College London, Institute of Psychiatry, Psychology and Neuroscience, London, UK.
Psychol Med ; 53(8): 3249-3260, 2023 Jun.
Article in En | MEDLINE | ID: mdl-37184076
ABSTRACT

BACKGROUND:

Alterations in heart rate (HR) may provide new information about physiological signatures of depression severity. This 2-year study in individuals with a history of recurrent major depressive disorder (MDD) explored the intra-individual variations in HR parameters and their relationship with depression severity.

METHODS:

Data from 510 participants (Number of observations of the HR parameters = 6666) were collected from three centres in the Netherlands, Spain, and the UK, as a part of the remote assessment of disease and relapse-MDD study. We analysed the relationship between depression severity, assessed every 2 weeks with the Patient Health Questionnaire-8, with HR parameters in the week before the assessment, such as HR features during all day, resting periods during the day and at night, and activity periods during the day evaluated with a wrist-worn Fitbit device. Linear mixed models were used with random intercepts for participants and countries. Covariates included in the models were age, sex, BMI, smoking and alcohol consumption, antidepressant use and co-morbidities with other medical health conditions.

RESULTS:

Decreases in HR variation during resting periods during the day were related with an increased severity of depression both in univariate and multivariate analyses. Mean HR during resting at night was higher in participants with more severe depressive symptoms.

CONCLUSIONS:

Our findings demonstrate that alterations in resting HR during all day and night are associated with depression severity. These findings may provide an early warning of worsening depression symptoms which could allow clinicians to take responsive treatment measures promptly.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Health context: 8_ODS3_consumo_sustancias_psicoactivas Database: MEDLINE Main subject: Depression / Depressive Disorder, Major Type of study: Prognostic_studies Limits: Humans Language: En Journal: Psychol Med Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Health context: 8_ODS3_consumo_sustancias_psicoactivas Database: MEDLINE Main subject: Depression / Depressive Disorder, Major Type of study: Prognostic_studies Limits: Humans Language: En Journal: Psychol Med Year: 2023 Document type: Article